190 related articles for article (PubMed ID: 8114691)
1. Suppression of albumin enhancer activity by H-ras and AP-1 in hepatocyte cell lines.
Hu J; Isom HC
Mol Cell Biol; 1994 Mar; 14(3):1531-43. PubMed ID: 8114691
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L
Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region.
Costa RH; Grayson DR
Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
5. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity.
Nerlov C; Rørth P; Blasi F; Johnsen M
Oncogene; 1991 Sep; 6(9):1583-92. PubMed ID: 1923525
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun.
Owen RD; Ostrowski MC
Proc Natl Acad Sci U S A; 1990 May; 87(10):3866-70. PubMed ID: 2111019
[TBL] [Abstract][Full Text] [Related]
7. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites.
Reddy MA; Langer SJ; Colman MS; Ostrowski MC
Mol Endocrinol; 1992 Jul; 6(7):1051-60. PubMed ID: 1324418
[TBL] [Abstract][Full Text] [Related]
8. ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene.
Yasuda H; Mizuno A; Tamaoki T; Morinaga T
Mol Cell Biol; 1994 Feb; 14(2):1395-401. PubMed ID: 7507206
[TBL] [Abstract][Full Text] [Related]
9. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
10. Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer.
Crescenzo-Chaigne B; Pillot J; Lilienbaum A
Virology; 1995 Oct; 213(1):231-40. PubMed ID: 7483267
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the human chromogranin A gene by its 5' distal regulatory element: novel effects of orientation, structure, flanking sequences, and position on expression.
Nolan EM; Cheung TC; Burton DW; Deftos LJ
Mol Cell Endocrinol; 1996 Nov; 124(1-2):51-62. PubMed ID: 9027324
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site.
Zhang XK; Dong JM; Chiu JF
J Biol Chem; 1991 May; 266(13):8248-54. PubMed ID: 1708774
[TBL] [Abstract][Full Text] [Related]
13. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element.
McBride K; Robitaille L; Tremblay S; Argentin S; Nemer M
Mol Cell Biol; 1993 Jan; 13(1):600-12. PubMed ID: 8417355
[TBL] [Abstract][Full Text] [Related]
14. Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations.
Liu C; Mason WS; Burch JB
J Virol; 1994 Apr; 68(4):2286-96. PubMed ID: 8139013
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the AP-1 sites in the IL-2 promoter.
Jain J; Valge-Archer VE; Rao A
J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
[TBL] [Abstract][Full Text] [Related]
16. Identification of a GABP alpha/beta binding site involved in the induction of oxytocin receptor gene expression in human breast cells, potentiation by c-Fos/c-Jun.
Hoare S; Copland JA; Wood TG; Jeng YJ; Izban MG; Soloff MS
Endocrinology; 1999 May; 140(5):2268-79. PubMed ID: 10218980
[TBL] [Abstract][Full Text] [Related]
17. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro.
Liu JK; DiPersio CM; Zaret KS
Mol Cell Biol; 1991 Feb; 11(2):773-84. PubMed ID: 1990282
[TBL] [Abstract][Full Text] [Related]
18. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
19. Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites.
Watanabe K; Kessler CA; Bachurski CJ; Kanda Y; Richardson BD; Stanek J; Handwerger S; Brar AK
Mol Endocrinol; 2001 Apr; 15(4):638-53. PubMed ID: 11266514
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
